Knobbe Martens Named Among Top Patent Prosecution Leaders in Patexia Report
IRVINE, Calif., April 1, 2026 – Knobbe Martens is pleased to share that the firm and several of its partners were highlighted in Patexia’s 2026 Patent Prosecution Leaders report for...
Knobbe Martens Receives Firm of the Year, Litigation Honors at 2026 Managing IP Americas Awards
IRVINE, Calif., April 10, 2026 – Knobbe Martens is proud to announce that the firm received multiple recognitions at the 2026 Managing IP Awards, including “IP Boutique Firm of the...
IP Considerations Following FDA Announcement on Flexibility for Cell and Gene Therapies
Key Takeaways: Manufacturing processes of cell and gene therapies (CGTs) may remain fluid well into development and even after FDA approval, and therefore sponsors of CGTs may benefit from patent...